Full-Time

Senior Manager Project Controls

Quantity Surverying

Posted on 5/15/2025

Amgen

Amgen

10,001+ employees

Develops biologic therapies for serious illnesses

Compensation Overview

$150.6k - $176.7k/yr

+ Bonus + Stock-based long-term incentives

Senior, Expert

Thousand Oaks, CA, USA

The Project Controls Senior Manager is required to be local and work onsite at Thousand Oaks, California.

Category
Public Health
Biology Lab & Research
Biology & Biotech
Requirements
  • Doctorate degree and 2 years of Engineering and capital projects delivery experience
  • Master’s degree and 4 years of Engineering and capital projects delivery experience
  • Bachelor’s degree and 6 years of Engineering and capital projects delivery experience
  • Associate’s degree and 10 years of Engineering and capital projects delivery experience
  • High school diploma / GED and 12 years of Engineering and capital projects delivery experience
Responsibilities
  • Managing project controls from funding through close out, including compliance to processes and policies.
  • Assisting Project Controls Director in developing project strategies and associated financing
  • Working closely with the Front-End Planning team to develop conceptual estimates and schedules.
  • Developing strategies and negotiating pricing for subcontractor scopes of work, reviewing, and analyzing engineer/contractor bids with GSS
  • Monitoring and evaluating engineering and contractors’ physical progress.
  • Addressing progress and delay claims from contractors
  • Analysis and accurate review of engineering / construction cost forecasts against scope
  • Reviewing and approving engineer and contractor buy outs, change orders and invoices.
  • Preparing monthly cost reports and project status reports for senior management both on site and corporately.
  • Lead the development, monitoring and reporting of project schedules and cash flow to enable accurate capital LE predication for their portfolio.
  • Leading risk analysis reviews for cost estimates, forecasts and schedules using applicable software packages.
  • Working with Amgen Buying Centre and Accounts Payable to resolve invoice payment issues and queries.
  • Overseeing the closeout of contracts, purchase orders and subsequent projects within their portfolio.
  • Monitoring and managing Capitalized Overhead across all projects and sites including planning, hiring, and charging processes.
  • Exhibiting proactive safety leadership and behavior
  • Communicating on and escalating on project matters and/or project controls performance for their portfolio to Site Sponsors and Engineering leadership
  • Overseeing their portfolio’s project controls effectiveness and compliance utilizing strong analytical views to lead the project teams to ensure proper evaluation and analysis.
  • Supporting Engineering Digital Transformation activities/workstreams by providing project controls subject matter expertise.
Desired Qualifications
  • 8 or more years within engineering or construction experience in the life sciences pharmaceutical/biotechnology industry executing project controls on projects (Funding, Estimating, Cost Management, Scheduling, Compliance, Contract Strategy)
  • Strong analytic and problem-solving ability
  • Excellent organizational and task management skills
  • Effective communication skills and ability to translate / communicate details summarized to a variety of audiences.
  • Ability to operate in a matrixed or team environment with site, functional, and executive leadership.
  • Demonstrated ability to lead teams and build strong relationships across the network.
  • Expertise and knowledge leading project controls internally and across external vendors
  • Understanding of the business aspects of projects to provide solutions to problems that require ingenuity and creativity.
  • Experience in progress measurement methods such as Earned Value Management
  • Experience in cost and scheduling software packages and data mining programs such as Power Bi
  • Understanding workflows and dimensions of BIM and opportunities for integration with cost and schedule when managing capital projects
  • Experience of procurement methods and contracts

Amgen develops medicines aimed at treating serious illnesses, focusing on biotechnology. The company researches, develops, and sells biologic therapies, which are derived from living organisms, to address conditions like cancer, cardiovascular diseases, and autoimmune disorders. Amgen's products work by utilizing biological processes to create effective treatments for patients. Unlike many competitors, Amgen emphasizes a strong commitment to research and development, reinvesting a large portion of its earnings to discover new therapies. The goal of Amgen is to improve patient care and outcomes by providing effective therapeutic solutions.

Company Size

10,001+

Company Stage

IPO

Headquarters

Thousand Oaks, California

Founded

1980

Simplify Jobs

Simplify's Take

What believers are saying

  • Amgen's investment in AI aligns with trends in biotechnology innovation.
  • Institutional investments indicate strong market confidence in Amgen's growth.
  • FTC clearance of the Horizon merger may ease future regulatory hurdles.

What critics are saying

  • Competitors' AI-driven drug discovery could outpace Amgen's traditional R&D methods.
  • FTC scrutiny of mergers may complicate Amgen's future growth strategy.
  • Advancements in quantum technologies could pose a competitive threat to Amgen.

What makes Amgen unique

  • Amgen focuses on biologic therapies derived from living organisms.
  • The company has a strong pipeline of potential new therapies in development.
  • Amgen's acquisition of Horizon Therapeutics enhances its rare disease portfolio.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Professional Development Budget

Conference Attendance Budget

Company News

MarketBeat
Jan 28th, 2024
Factory Mutual Insurance Co. Makes New Investment in Amgen Inc. (NASDAQ:AMGN)

Factory Mutual Insurance Co. purchased a new position in Amgen Inc. (NASDAQ:AMGN - Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 53,500 shares of the medical research company's stock, valued at approxim

The Quantum Insider
Jan 16th, 2024
Honeywell Announces the Closing of $300 Million Equity Investment Round for Quantinuum at $5 Billion Pre-Money Valuation

JPMorgan Chase has one of the world's most highly regarded specialist teams working on quantum technologies within the financial services industry and has been working with Quantinuum and its predecessor companies since 2020.

ETF Daily News
Dec 17th, 2023
Northwest Quadrant Wealth Management LLC Invests $237,000 in Amgen Inc. (NASDAQ:AMGN)

Northwest Quadrant Wealth Management LLC bought a new position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 883 shares of the medical research company’s stock, valued at approximately $237,000. A number of other institutional investors […]

Horizon Therapeutics
Sep 21st, 2023
Rule 2.7 Announcement: Amgen Inc to Acquire Horizon Therapeutics plc | Horizon Therapeutics plc

The Investor Relations website contains information about Horizon Therapeutics plc's business for stockholders, potential investors, and financial analysts.

BioSpace
Sep 19th, 2023
Amgen-Horizon Merger Clearance a Setback to FTC’s Antitrust Enforcement Plans

The consent agreement struck between the FTC and Amgen and Horizon Therapeutics could have significant implications for ongoing and future M&A challenges, experts told BioSpace.